🔎 Trials Near Me

Home › Alzheimer's Disease › Indiana

Alzheimer's Disease clinical trials in Indiana

16 studies for Alzheimer's Disease are looking for participants at sites in Indiana.

Cities in Indiana

Dominantly Inherited Alzheimer Network (DIAN)

  • Indiana University-Indiana Alzheimer Disease Center, Indianapolis
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT00869817

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

  • NexGen Research, Fort Wayne
  • Josephson Wallack Munshower Neurology P.C., Indianapolis
RecruitingPhase 4
Ages 50 and older · All sexes · Updated Sep 25, 2026 · NCT07633470

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • Indiana University Health Neuroscience Center, Indianapolis
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • Josephson Wallack Munshower Neurology, PC, Indianapolis
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Sep 17, 2026 · NCT06976203

A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD

  • Clinical Trial Site, Indianapolis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05231785

Alzheimer's Disease Genetics Study

  • Participants are being recruited from all over the United States, Nationwide
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT00064870

Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes

  • Eskenazi Health, Indianapolis
Recruiting
Ages 65 and older · All sexes · Updated Aug 20, 2026 · NCT05643144

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • Indiana University School of Medicine, Indianapolis
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT06647498

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • Indiana University School of Medicine, Indianapolis
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT05552157

A Feasiblity Study of Green Activity Program for People Living With Memory Challenges

  • Indiana University Bloomington, Bloomington
Recruiting
Ages 45 and older · All sexes · Updated Jul 15, 2026 · NCT06403345

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Care Access - South Indianapolis, Indianapolis
  • Josephson Wallack Munshower Neurology, PC, Indianapolis
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Jul 7, 2026 · NCT07602582

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • Indiana University, Indianapolis
RecruitingObservational study
Ages 25 to 55 · All sexes · Updated May 18, 2026 · NCT04165109

Late Onset Alzheimer's Disease

  • Indiana University, Bloomington
  • NCRAD at Indiana University, Indianapolis
RecruitingObservational studyHealthy volunteers welcome
Ages 55 and older · All sexes · Updated May 18, 2026 · NCT05010603

Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study

  • Indiana University, Indianapolis
Recruiting
Ages 40 to 75 · All sexes · Updated May 6, 2026 · NCT05573490

Nicotinic Acid for the Treatment of Alzheimer's Disease

  • IU Health Neuroscience Center, Indianapolis
RecruitingPhase 1/2
Ages 60 to 85 · All sexes · Updated Mar 5, 2026 · NCT06582706

I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms

  • IU Health, Indianapolis
  • Community Health Network, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Nov 24, 2025 · NCT05733520

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.